IGF-1 as screening tool for acromegaly and adult-onset growth hormone deficiency in the Netherlands.

Mark R PostmaAndré P van BeekMelanie M van der KlauwEef G W M Lentjes Anneke C Muller Kobold

Published in: Clinical endocrinology (2023)

Highly variable diagnostic and treatment outcomes in acromegaly and AGHD in the Netherlands can be attributed to increased variability of IGF-1 upon conversion to SD scores and low adherence to clinical guidelines.

Keyphrases

growth hormone
clinical practice
type diabetes
replacement therapy
metabolic syndrome
cell proliferation